Author: IQ TIMES MEDIA
2025-11-21T17:39:08.336Z Share Facebook Email X LinkedIn Reddit Bluesky WhatsApp Copy link lighning bolt icon An icon in the shape of a lightning bolt. Impact Link Save Saved Read in app This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Have an account? Log in. A new Google update enabled AirDrop and Quick Share interoperability between iPhone and Android devices. Pixel 10 users can now transfer files directly to iPhones, iPads, and Macs via AirDrop. Google plans to expand this secure, peer-to-peer sharing feature to more Android devices. Another wall between iPhones and Androids…
(Reuters) -The U.S. Food and Drug Administration said on Friday that it will convene a panel of experts on January 22, 2026, to review an request by Swedish Match USA, a unit of Philip Morris International, to market its ZYN nicotine pouches as lower-risk alternatives to cigarettes.The advisory committee will examine modified-risk applications for 20 ZYN products, each sold in 3-mg and 6-mg strengths.The FDA in January 2025 cleared the same 20 products for sale after reviewing them under its premarket system for new tobacco products, allowing them to remain on the U.S. market.That decision did not allow Swedish Match…
(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals’ blood disorder therapy, the health regulator said on Friday.The pediatric patient died about 10 months after starting Takeda’s drug Adzynma as a preventive therapy, the agency said.The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.AdvertisementAdvertisementAdvertisementAdvertisementThe FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.Takeda did not immediately respond to Reuters request for comment.Adzynma, approved…
By Ana ManoSAO PAULO (Reuters) -Brazilian agricultural research agency Embrapa has received the greenlight from health agency Anvisa to research the cannabis plant, a landmark move that puts farming powerhouse Brazil a step closer towards authorizing its cultivation.In an interview on Friday, Embrapa researcher Daniela Bittencourt welcomed Anvisa’s decision this week, which gives the agency unprecedented permission to build its first-ever cannabis seed bank and develop projects to genetically improve the plant for various applications.Embrapa will also research hemp used to produce fibers, Bittencourt said.”This is only the beginning,” Bittencourt said by telephone from Brasilia. “Our plan is to carry…
Former TV host and Emmy-winning musician John Tesh is opening up about his battle with prostate cancer over the last 10 years, and in a new interview with “Good Morning America,” Tesh credited his wife, actress Connie Sellecca, for saving his life.”I’m incredibly grateful, because it has been literally a 10-and-a-half-year journey [from] when I was first diagnosed in 2015,” Tesh, 73, said.Tesh was 63 when doctors diagnosed him with a rare and aggressive form of prostate cancer and estimated he might live for only about 18 months more.ABC News – PHOTO: John Tesh appears on Good Morning America, Nov.…
NEW YORK (AP) — A new play exploring the complex relationship between playwright and AIDS activist Larry Kramer and Dr. Anthony Fauci, the longtime top U.S. infectious disease expert, will make its premiere early next year in New York under the direction of Tony Award-winner Daniel Fish.“Kramer/Fauci” will star Tony-winner Will Brill from “Stereophonic” and Thomas Jay Ryan, who starred in the film “Henry Fool.” It will play The Jack H. Skirball Center for the Performing Arts between Feb. 11-21, The AP has learned.Fish, whose 2019 production of Rodgers and Hammerstein’s “Oklahoma!” won the Tony Award for best musical revival,…
SAN DIEGO (AP) — The Trump administration has sued California for providing in-state college tuition, scholarships, and state-funded financial aid to students who do not have legal status to be in the United States.The lawsuit, filed Thursday in the U.S. District Court for the Eastern District of California, alleges the practice harms U.S. citizens and encourages illegal immigration. Among the defendants are the state, top state officials, and the state’s two public university systems, the University of California and California State.President Donald Trump’s administration has filed similar lawsuits against policies in other states, including Illinois, Oklahoma, Minnesota, Kentucky and Texas.…
2025-11-21T13:44:17.811Z Share Facebook Email X LinkedIn Reddit Bluesky WhatsApp Copy link lighning bolt icon An icon in the shape of a lightning bolt. Impact Link Save Saved Read in app This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Have an account? Log in. Business Insider is seeking nominations for our list of the rising stars of brand marketing. We’re highlighting talented up-and-coming brand marketers poised to become tomorrow’s leaders. Please submit your nominations by December 23. Business Insider is seeking nominations for a forthcoming list of the rising stars of brand marketing.Please…
NASHVILLE, Tenn. (AP) — A group of public school students’ parents and taxpayers has filed a lawsuit challenging Tennessee’s new statewide school voucher program, saying that allocating nearly $150 million in state funding to help parents send their kids to private schools is unconstitutional.In their lawsuit filed Thursday in Davidson County Chancery Court, the plaintiffs requested injunctions to block the Republican-backed law while the case proceeds.Similar scholarship and voucher initiatives have proliferated in Republican-led states such as Texas, which passed a $1 billion program. States have increasingly offered vouchers to families beyond only the neediest ones, contributing to budget concerns…
If you’re feeling like your workload has increased in 2025, you’re not the only one.A new EY survey of 15,000 workers found that nearly two-thirds of employees believe their workload has increased in the last 12 months.AI isn’t directly to blame, but, as with most workplace trends today, it’s a big part of the story.”Our research doesn’t show that AI is actually increasing workloads,” Kim Billeter, EY’s global people consulting leader, told Business Insider.Instead, broader anxieties about AI in the workplace — including fears of skill erosion, a lack of training, and uncertainty over how technology will affect roles —…